Medicare Enrolled
Dr. Varsha Taskar, MD
Pulmonary Disease · Augusta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Taskar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Taskar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Taskar
Dr. Varsha Taskar is a pulmonary disease specialist in Augusta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Taskar performed 1,400 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Taskar received a total of $4,612 from 41 pharmaceutical and/or device companies across 114 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Taskar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 34% volume in GA
$4,612 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,400
Medicare services
Top 34% in GA for pulmonary disease
Not available
Unique patients (not deduplicated)
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
351 | $70 | $172 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
217 | $6 | $20 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
158 | $6 | $82 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
135 | $9 | $74 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
103 | $7 | $143 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
101 | $62 | $162 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
96 | $15 | $56 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $46 | $111 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
38 | $167 | $515 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
28 | $28 | $652 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $104 | $283 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
19 | $82 | $543 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
17 | $93 | $232 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $56 | $165 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
16 | $101 | $298 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
14 | $88 | $582 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
12 | $8 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$4,612
Total received (2018-2024)
Avg $659/year across 7 years
Top 36% in GA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
114
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$509
2023
$842
2022
$1,395
2021
$445
2020
$426
2019
$352
2018
$644
Payments by company (2024)
Boehringer Ingelheim Pharmaceuticals, Inc.
$177
Actelion Pharmaceuticals US, Inc.
$109
Merck Sharp & Dohme LLC
$87
Pulmonx Corporation
$33
VERTEX PHARMACEUTICALS INCORPORATED
$26
ANI Pharmaceuticals, Inc.
$21
GlaxoSmithKline, LLC.
$14
AstraZeneca Pharmaceuticals LP
$14
Aurinia Pharma U.S., Inc.
$14
Mylan Specialty L.P.
$14
Top 3 companies account for 73.3% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$709
Insmed, Inc.
$595
Actelion Pharmaceuticals US, Inc.
$381
United Therapeutics Corporation
$312
Inspire Medical Systems, Inc.
$205
Inari Medical, Inc.
$172
Chiesi USA, Inc.
$162
Mylan Specialty L.P.
$141
Merck Sharp & Dohme LLC
$139
Boston Scientific Corporation
$132
Genentech USA, Inc.
$127
JAZZ PHARMACEUTICALS INC.
$125
Vertex Pharmaceuticals Incorporated
$122
Jazz Pharmaceuticals Inc.
$121
AbbVie, Inc.
$111
Pulmonx Corporation
$105
ANI Pharmaceuticals, Inc.
$98
Harmony Biosciences LLC
$95
Mallinckrodt LLC
$94
Medtronic Vascular, Inc.
$92
HARMONY BIOSCIENCES LLC
$84
Shionogi Inc
$62
CHIESI USA, INC.
$56
Gilead Sciences, Inc.
$36
GlaxoSmithKline, LLC.
$34
La Jolla Pharmaceutical Company
$30
VERTEX PHARMACEUTICALS INCORPORATED
$26
Shire North American Group Inc
$25
Sandoz Inc.
$23
Baxter Healthcare
$22
Amgen Inc.
$22
Philips Electronics North America Corporation
$22
Allergan Inc.
$19
Alexion Pharmaceuticals, Inc.
$17
Novo Nordisk Inc
$17
AstraZeneca Pharmaceuticals LP
$14
Aurinia Pharma U.S., Inc.
$14
PARI RESPIRATORY EQUIPMENT, INC.
$14
Janssen Pharmaceuticals, Inc
$13
Takeda Pharmaceuticals U.S.A., Inc.
$13
PFIZER INC.
$11
Top 3 companies account for 36.5% of all-time payments
Associated products mentioned in payments ›
(8750) DS BiPAP autoSV · ACTHAR · AREXVY · Arikayce · BETHKIS · BRONCHITOL · CHARTIS CATHETER · CUROSURF · Cayston · Creon · EkoSonic · Enbrel · FASENRA · FLOWTRIEVER CATHETER · Fetroja · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · Inspire Upper Airway Stimulation System · KALYDECO · Kitabis Pak · LUPKYNIS · OFEV · ORENITRAM · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Pulmonx Endobronchial Valve EBV · REMODULIN · Resolute · Rybelsus · S · TOBI PODHALER · TOBI Podhaler · TRELEGY ELLIPTA · TREPROSTINIL · TRIKAFTA · TYVASO · Tobi Podhaler · ULTOMIRIS · UPTRAVI · WINREVAIR · Wakix · XARELTO · XYWAV · Xyrem · YUPELRI · Yupelri · ZENPEP
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
26
County median income
$53,197
Nearest hospital to ZIP centroid (approximate)
WELLSTAR MCG HEALTH, AFFILIATED WITH MED COL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Taskar is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Taskar experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Taskar performed 351 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Taskar receive payments from pharmaceutical companies?
Yes. Dr. Taskar received a total of $4,612 from 41 companies across 114 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Taskar's costs compare to other pulmonary diseases in Augusta?
Dr. Taskar's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Taskar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Augusta
Browse pulmonary diseases in Augusta ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in GA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in GA
Which GA pulmonary diseases receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Insmed, Inc. Payments to Doctors
See all physicians who received payments from Insmed, Inc.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology